Gaithersburg, MD, United States of America

Josephine Mary McAuliffe

This inventor holds 11 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Medimmune Limited, Humabs Biomed Sa, Other. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josephine Mary McAuliffe. Retrieved from https://idiyas.com/inventor/josephine-mary-mcauliffe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Gatihersburg, MD (US) (2016)
Gailthersburg, MD (US) (2019)
Gaithersburg, MD (US) (2014 - 2024)

Company Filing History:

1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492240 - NEUTRALIZING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF (2025-12-09),

2. 12325740 - Neutralizing anti-influenza B antibodies and uses thereof (2025-06-10),

3. 11932682 - Neutralizing anti-influenza A antibodies and uses thereof (2024-03-19),

4. 11787853 - Neutralizing anti-influenza b antibodies and uses thereof (2023-10-17),

5. 11186627 - Neutralizing anti-influenza A antibodies and uses thereof (2021-11-30),

6. 11174304 - Neutralizing anti-influenza B antibodies and uses thereof (2021-11-16),

7. 10519221 - Neutralizing anti-influenza B antibodies and uses thereof (2019-12-31),

8. 10494419 - Neutralizing anti-influenza A antibodies and uses thereof (2019-12-03),

9. 10294292 - Neutralizing anti-influenza B antibodies and uses thereof (2019-05-21),

10. 9499590 - Antibodies against and methods for producing vaccines for respiratory syncytial virus (2016-11-22),

11. 8852608 - Antibodies against and methods for producing vaccines for respiratory syncytial virus (2014-10-07),

Title: The Innovative Contributions of Josephine Mary McAuliffe

Introduction

Josephine Mary McAuliffe is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for influenza viruses. With a total of 10 patents to her name, her work has had a substantial impact on medical research and treatment options.

Latest Patents

Among her latest patents is the invention titled "Neutralizing anti-influenza B antibodies and uses thereof." This invention relates to antibodies and antigen binding fragments that can bind to the influenza B virus hemagglutinin (HA) and neutralize the virus in two distinct lineages. In one embodiment, the antibody or fragment is capable of binding to the influenza B virus hemagglutinin and neutralizing the virus in both Yamagata and Victoria lineages. Another notable patent is "Neutralizing anti-influenza A antibodies and uses thereof," which involves antibodies and binding fragments that can bind to the influenza A virus hemagglutinin and neutralize at least one group 1 subtype and one group 2 subtype of the virus.

Career Highlights

Josephine has worked with several reputable companies throughout her career, including MedImmune Limited and Humabs Biomed SA. Her experience in these organizations has allowed her to develop her expertise in antibody research and innovation.

Collaborations

Josephine has collaborated with notable colleagues such as Qing Zhu and Ebony Benjamin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Josephine Mary McAuliffe's work in the field of biotechnology, particularly her patents related to influenza antibodies, showcases her dedication to advancing medical science. Her contributions continue to influence the development of effective treatments for viral infections.

Profile summary based on public USPTO records.